Your basket is currently empty!
NICE give nivolumab NO as initial recommendation
NICE give nivolumab NO as initial recommendation
We were all hoping for good news regarding the NICE appraisal of ...
News Archive
NICE
NICE approval of immunotherapy for melanoma is hopeful for kidney cancer.
By: Dr Rebecca Case-Upton BSc (Hons), PhD
Kidney Cancer UK, Medical Publications
It is great news for patients ...
NICE Recommendation of axitinib
Kidney Cancer UK welcomes the news today that the National Institute for Health and Care Excellence (NICE) are ...
NICE releases preliminary guidance to recommend Inlyta® (axitinib) for the treatment of advanced kidney cancer
The National Institute for Health and Care Excellence (NICE) released preliminary guidance today in the ...
NICE appeal verdict to postpone the decision and undertake a reappraisal causes disappointment
JAMES WHALE FUND IS DISAPPOINTED WITH THE NICE APPEAL VERDICT TO POSTPONE THE DECISION AND UNDERTAKE A REAPPRAISAL ...
NICE denies patients with terminal kidney cancer access to Axitinib
Broadcaster James Whale MBE, Chairman of the Kidney Cancer UK and himself a kidney cancer survivor, commented that ...
